Patents by Inventor Peter Laurence

Peter Laurence has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240052426
    Abstract: The present invention relates generally to nucleic acid molecules in respect of which changes to DNA methylation levels are indicative of the onset or predisposition to die onset of a neoplasm. More particularly, the present invention is directed to nucleic acid molecules in respect of which changes to DNA methylation levels are indicative of the onset and/or progression of a large intestine neoplasm, such as an adenoma or adenocarcinoma. The DNA methylation status of the present invention is useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal neoplasms, such as colorectal adenocarcinomas. Accordingly, in a related aspect the present invention is directed to a method of screening for the onset, predisposition to the onset and/or progression of a neoplasm by screening for modulation in DNA methylation of one or more nucleic acid molecules.
    Type: Application
    Filed: May 4, 2023
    Publication date: February 15, 2024
    Inventors: Jason Peter Ross, Horace Drew, Michael Buckley, Peter Laurence Molloy, Susan Margaret Mitchell, Konsta Rainer Duesing, Zheng-Zhou Xu
  • Publication number: 20210316297
    Abstract: This disclosure provides systems, apparatuses, and methods for liquid transfer and performing reactions. In one aspect, a system includes a liquid transfer device having a housing having a pipette tip and a plunger assembly; and a reaction chamber, wherein the housing of the liquid transfer device is configured to sealably engage with the reaction chamber. In another aspect, a liquid transfer device including a housing having a pipette tip; and a plunger assembly disposed within the housing and the pipette tip, wherein a portion of the plunger assembly is configured to engage a fluid reservoir such that the plunger assembly remains stationary relative to the fluid reservoir and the housing moves relative to the plunger assembly.
    Type: Application
    Filed: April 23, 2021
    Publication date: October 14, 2021
    Inventors: Simon Roderick Grover, Paul Graham Wilkins, Nick David Rollings, Peter Laurence Mayne, Wai Ting Chan, Natalie Frances Scott, Olivier Fernand Flick, Henry Charles Innes, Martyn Gray Darnbrough Beedham, Nicholas David Long, Richard John Hammond
  • Patent number: 11106800
    Abstract: A kernel is monitored for occurrence of a set of Kprobes. A determination is made that a Strategy that makes use of at least one Kprobe included in the set of Kprobes has been matched. A remedial action is taken in response to the determination. Examples of such remedial actions include generating an alert and terminating a network connection.
    Type: Grant
    Filed: November 27, 2019
    Date of Patent: August 31, 2021
    Assignee: Capsule8, Inc.
    Inventor: Peter Laurence Markowsky
  • Patent number: 11033894
    Abstract: This disclosure provides systems, apparatuses, and methods for liquid transfer and performing reactions. In one aspect, a system includes a liquid transfer device having a housing having a pipette tip and a plunger assembly; and a reaction chamber, wherein the housing of the liquid transfer device is configured to sealably engage with the reaction chamber. In another aspect, a liquid transfer device including a housing having a pipette tip; and a plunger assembly disposed within the housing and the pipette tip, wherein a portion of the plunger assembly is configured to engage a fluid reservoir such that the plunger assembly remains stationary relative to the fluid reservoir and the housing moves relative to the plunger assembly.
    Type: Grant
    Filed: August 7, 2018
    Date of Patent: June 15, 2021
    Assignee: ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
    Inventors: Simon Roderick Grover, Paul Graham Wilkins, Nick David Rollings, Peter Laurence Mayne, Wai Ting Chan, Natalie Frances Scott, Olivier Fernand Flick, Henry Charles Innes, Martyn Gray Darnbrough Beedham, Nicholas David Long, Richard John Hammond
  • Publication number: 20200172963
    Abstract: The present invention relates generally to nucleic acid molecules in respect of which changes to DNA methylation levels are indicative of the onset or predisposition to the onset of a neoplasm. More particularly, the present invention is directed to nucleic acid molecules in respect of which changes to DNA methylation levels are indicative of the onset and/or progression of a large intestine or breast neoplasm, such as an adenoma or adenocarcinoma. The DNA methylation status of the present invention is useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal or breast neoplasms, such as colorectal or breast adenocarcinomas. Accordingly, in a related aspect the present invention is directed to a method of screening for the onset, predisposition to the onset and/or progression of a neoplasm by screening for modulation in DNA methylation of one or more nucleic acid molecules.
    Type: Application
    Filed: November 14, 2019
    Publication date: June 4, 2020
    Inventors: Peter Laurence Molloy, Lawrence Charles Lapointe, Susanne Kartin Pedersen, Susan Margaret Mitchell
  • Patent number: 10526642
    Abstract: The present invention relates generally to nucleic acid molecules in respect of which changes to DNA methylation levels are indicative of the onset or predisposition to the onset of a neoplasm. More particularly, the present invention is directed to nucleic acid molecules in respect of which changes to DNA methylation levels are indicative of the onset and/or progression of a large intestine or breast neoplasm, such as an adenoma or adenocarcinoma. The DNA methylation status of the present invention is useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal or breast neoplasms, such as colorectal or breast adenocarcinomas. Accordingly, in a related aspect the present invention is directed to a method of screening for the onset, predisposition to the onset and/or progression of a neoplasm by screening for modulation in DNA methylation of one or more nucleic acid molecules.
    Type: Grant
    Filed: August 24, 2012
    Date of Patent: January 7, 2020
    Assignees: Commonwealth Scientific and Industrial Research Organisation, Clinical Genomics Pty. Ltd.
    Inventors: Peter Laurence Molloy, Lawrence Charles Lapointe, Susanne Kartin Pedersen, Susan Margaret Mitchell
  • Publication number: 20190244148
    Abstract: A system, method and program product for optimizing a risk transfer strategy for a resource provider. A system is disclosed having: an interface for accessing event data from a resource provider; a machine learning system that analyzes the event data at different risk levels and detects and quantifies negative correlations among the different risk levels; and a risk transfer optimization system that generates an optimized risk transfer strategy for the resource provider based on detected negative correlations.
    Type: Application
    Filed: February 8, 2019
    Publication date: August 8, 2019
    Inventors: Jeffrey Bernard Scott, Subhashish Dutta, Peter Laurence Forester, Jennifer Lee Gravelle, Douglas Bruce Collins, Travis Cole Rosecrans
  • Publication number: 20190039059
    Abstract: This disclosure provides systems, apparatuses, and methods for liquid transfer and performing reactions. In one aspect, a system includes a liquid transfer device having a housing having a pipette tip and a plunger assembly; and a reaction chamber, wherein the housing of the liquid transfer device is configured to sealably engage with the reaction chamber. In another aspect, a liquid transfer device including a housing having a pipette tip; and a plunger assembly disposed within the housing and the pipette tip, wherein a portion of the plunger assembly is configured to engage a fluid reservoir such that the plunger assembly remains stationary relative to the fluid reservoir and the housing moves relative to the plunger assembly.
    Type: Application
    Filed: August 7, 2018
    Publication date: February 7, 2019
    Inventors: Simon Roderick Grover, Paul Graham Wilkins, Nick David Rollings, Peter Laurence Mayne, Wai Ting Chan, Natalie Frances Scott, Olivier Fernand Flick, Henry Charles Innes, Martyn Gray Darnbrough Beedham, Nicholas David Long, Richard John Hammond
  • Publication number: 20190024188
    Abstract: The present invention relates generally to nucleic acid molecules in respect of which changes to the DNA or to the RNA or protein expression profiles are indicative of the onset, predisposition to the onset and/or progression of a neoplasm. More particularly, the present invention is directed to nucleic acid molecules in respect of which changes to the DNA or to the RNA or protein expression profiles are indicative of the onset and/or progression of a large intestine neoplasm, such as a adenoma or an adeocarcinoma. The DNA or the expression profiles of the present invention are useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal neoplasms, such as colorectal adenocarcinoma.
    Type: Application
    Filed: October 2, 2018
    Publication date: January 24, 2019
    Applicants: CLINICAL GENOMICS PTY. LTD., COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
    Inventors: Lawrence C. LAPOINTE, Robert DUNNE, Graeme P. YOUNG, Trevor John LOCKETT, William J. WILSON, Peter Laurence MOLLOY
  • Patent number: 10040061
    Abstract: This disclosure provides systems, apparatuses, and methods for liquid transfer and performing reactions. In one aspect, a system includes a liquid transfer device having a housing having a pipette tip and a plunger assembly; and a reaction chamber, wherein the housing of the liquid transfer device is configured to sealably engage with the reaction chamber. In another aspect, a liquid transfer device including a housing having a pipette tip; and a plunger assembly disposed within the housing and the pipette tip, wherein a portion of the plunger assembly is configured to engage a fluid reservoir such that the plunger assembly remains stationary relative to the fluid reservoir and the housing moves relative to the plunger assembly.
    Type: Grant
    Filed: April 28, 2016
    Date of Patent: August 7, 2018
    Assignee: Alere Switzerland GMBH
    Inventors: Simon Roderick Grover, Paul Graham Wilkins, Nick David Rollings, Peter Laurence Mayne, Wai Ting Chan, Natalie Frances Scott, Olivier Fernand Flick, Henry Charles Innes, Martyn Gray Darnbrough Beedham, Nicholas David Long, Richard John Hammond
  • Publication number: 20180119432
    Abstract: An extendible scaffold unit comprises at least two support platforms or two support frames (12, 14, 16), at least one of the support platforms or support frames (12, 14, 16) being movable between a lowered position and a raised position, a plurality of scissor linkages (35, 36, 37) linking one support platform or support frame (12, 14, 16) with a next support platform or support frame (12, 14, 16), each of the scissor linkages (35, 36, 37) including a plurality of legs (26, 28, 30, 32), each scissor linkage having a leg pivotally connected to or near a corner of one of the support platforms or support frames and a leg pivotally connected to or near a corner of a next support platform support frame, wherein a leg is pivotally connected at or near each corner of a support platform or support frame. By providing a leg pivotally connected at or near each corner of a support platform or support frame, the support platform or support frame is supported at or near each corner when in the raised position.
    Type: Application
    Filed: May 11, 2016
    Publication date: May 3, 2018
    Inventors: Gregory Finlay, Peter Laurence Doljanin
  • Publication number: 20160288116
    Abstract: This disclosure provides systems, apparatuses, and methods for liquid transfer and performing reactions. In one aspect, a system includes a liquid transfer device having a housing having a pipette tip and a plunger assembly; and a reaction chamber, wherein the housing of the liquid transfer device is configured to sealably engage with the reaction chamber. In another aspect, a liquid transfer device including a housing having a pipette tip; and a plunger assembly disposed within the housing and the pipette tip, wherein a portion of the plunger assembly is configured to engage a fluid reservoir such that the plunger assembly remains stationary relative to the fluid reservoir and the housing moves relative to the plunger assembly.
    Type: Application
    Filed: April 28, 2016
    Publication date: October 6, 2016
    Inventors: Simon Roderick Grover, Paul Graham Wilkins, Nick David Rollings, Peter Laurence Mayne, Wai Ting Chan, Natalie Frances Scott, Olivier Fernand Flick, Henry Charles Innes, Martyn Gray Darnbrough Beedham, Nicholas David Long, Richard John Hammond
  • Patent number: 9352312
    Abstract: This disclosure provides systems, apparatuses, and methods for liquid transfer and performing reactions. In one aspect, a system includes a liquid transfer device having a housing having a pipette tip and a plunger assembly; and a reaction chamber, wherein the housing of the liquid transfer device is configured to sealably engage with the reaction chamber. In another aspect, a liquid transfer device including a housing having a pipette tip; and a plunger assembly disposed within the housing and the pipette tip, wherein a portion of the plunger assembly is configured to engage a fluid reservoir such that the plunger assembly remains stationary relative to the fluid reservoir and the housing moves relative to the plunger assembly.
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: May 31, 2016
    Assignee: Alere Switzerland GMBH
    Inventors: Simon Roderick Grover, Paul Graham Wilkins, Nick David Rollings, Peter Laurence Mayne, Wai Ting Chan, Natalie Frances Scott, Olivier Fernand Flick, Henry Charles Innes, Martyn Gray Darnbrough Beedham, Nicholas David Long, Richard John Hammond
  • Patent number: 9200652
    Abstract: The fastening device 10 of FIG. 3 is provided for fastening a flexible material to a structure. The fastening device 10 comprises an elongate fastening member 12 having a male portion 11 and a base portion 13. The base portion 13 provides a plurality of indentations 14 at spaced apart intervals along the length of the fastening member 12. The indentations 16 are adapted for securing the fastening member 12 to the structure with the use of fasteners extending through the indentations 16. The male portion 11 is shaped for receiving an elongate clip-type retaining member 24. The male portion 11 provides a channel 15 on its surface facing away from the base portion 13 for cooperating with a projection 17 on an inner surface of the clip-type retaining member 24. The channel 15 is positioned for alignment with the projection 17 for receiving the flexible material as the projection 17 forces the flexible material into the channel 15.
    Type: Grant
    Filed: July 4, 2014
    Date of Patent: December 1, 2015
    Assignee: KBL HOLDINGS PTY LTD
    Inventor: Peter Laurence
  • Publication number: 20150111884
    Abstract: Described herein are antibacterial compounds of formula I, methods for making the compounds, pharmaceutical compositions containing the compounds and methods of treating bacterial infections utilizing the compounds and pharmaceutical composition.
    Type: Application
    Filed: December 23, 2014
    Publication date: April 23, 2015
    Inventors: Michael P. Curtis, Timothy Allan Johnson, Manjinder S. Lall, Peter Laurence Toogood, Joseph S. Warmus
  • Patent number: 8952149
    Abstract: Described herein are antibacterial compounds of formula I, methods for making the compounds, pharmaceutical compositions containing the compounds and methods of treating bacterial infections utilizing the compounds and pharmaceutical composition.
    Type: Grant
    Filed: September 24, 2013
    Date of Patent: February 10, 2015
    Assignee: Zoetis LLC
    Inventors: Michael Curtis, Timothy Allan Johnson, Manjinder S. Lall, Peter Laurence Toogood, Joseph S. Warmus
  • Publication number: 20140315203
    Abstract: The present invention relates generally to nucleic acid molecules in respect of which changes to DNA methylation levels are indicative of the onset or predisposition to the onset of a neoplasm. More particularly, the present invention is directed to nucleic acid molecules in respect of which changes to DNA methylation levels are indicative of the onset and/or progression of a large intestine or breast neoplasm, such as an adenoma or adenocarcinoma. The DNA methylation status of the present invention is useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal or breast neoplasms, such as colorectal or breast adenocarcinomas. Accordingly, in a related aspect the present invention is directed to a method of screening for the onset, predisposition to the onset and/or progression of a neoplasm by screening for modulation in DNA methylation of one or more nucleic acid molecules.
    Type: Application
    Filed: August 24, 2012
    Publication date: October 23, 2014
    Applicants: Commonwealth Scientific and Industrial Research Organisation, Clinical Genomics Pty. Ltd.
    Inventors: Peter Laurence Molloy, Lawrence Charles Lapointe, Susanne Kartin Pedersen, Susan Margaret Mitchell
  • Publication number: 20140287940
    Abstract: The present invention relates generally to nucleic acid molecules in respect of which changes to the DNA or to the RNA or protein expression profiles are indicative of the onset, predisposition to the onset and/or progression of a neoplasm. More particularly, the present invention is directed to nucleic acid molecules in respect of which changes to the DNA or to the RNA or protein expression profiles are indicative of the onset and/or progression of a large intestine neoplasm, such as an adenoma or an adenocarcinoma. The DNA or the expression profiles of the present invention are useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal neoplasms, such as colorectal adenocarcinomas.
    Type: Application
    Filed: October 18, 2013
    Publication date: September 25, 2014
    Applicants: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION, CLINICAL GENOMICS PTY. LTD.
    Inventors: Lawrence C. LAPOINTE, Robert DUNNE, Graeme P. YOUNG, Trevor John LOCKETT, William J. WILSON, Peter Laurence MOLLOY
  • Publication number: 20140088093
    Abstract: Described herein are antibacterial compounds, methods for making the compounds, pharmaceutical compositions containing the compounds and methods of treating bacterial infections utilizing the compounds and pharmaceutical composition.
    Type: Application
    Filed: September 24, 2013
    Publication date: March 27, 2014
    Applicant: Zoetis LLC
    Inventors: Michael Curtis, Timothy Allan Johnson, Manjinder S. Lall, Peter Laurence Toogood, Joseph S. Warmus
  • Patent number: D788325
    Type: Grant
    Filed: October 23, 2015
    Date of Patent: May 30, 2017
    Assignee: KBL Holdings PTY LTD
    Inventor: Peter Laurence